Breast biopsy has shifted from open surgery to minimally invasive core needle biopsy, relying on high‑quality biopsy needles to provide accurate diagnosis with minimal trauma and excellent cosmetic outcomes. Jiangsu Changfeng Medical Industry Co., Ltd. produces biopsy needles optimized for breast tissue sampling, featuring fine needles, gentle penetration, and superior ultrasound compatibility. Our breast biopsy needles minimize scarring and tissue distortion while providing sufficient material for histopathological and immunohistochemical analysis. The ultra‑sharp tip ensures smooth insertion, while the precisely designed sampling notch captures intact tissue cores to evaluate tumor type, grade, hormone receptor status, and HER2 expression. Echogenic enhancements improve ultrasound visualization for accurate targeting of microcalcifications, masses, and architectural distortions. In benign breast disease evaluation, our biopsy needles help avoid unnecessary surgery by confirming non‑malignant conditions such as fibroadenoma and fibrocystic changes. In breast cancer diagnosis, they provide critical information for treatment planning including surgery, chemotherapy, radiotherapy, targeted therapy, and endocrine therapy. In neoadjuvant therapy assessment, they support post‑treatment biopsy to evaluate response. Our integrated R&D and production system ensures continuous improvement based on clinical feedback. We adhere to international standards for breast biopsy devices and provide full regulatory documentation. Committed to women’s health, we deliver reliable biopsy needles that support early and accurate breast cancer diagnosis. For breast‑specific biopsy needle details, customization options, clinical guidelines, and pricing, please contact our breast care specialists.